Home Special Topics Technology Offerings Content

Thiopeps - Thiostrepton derivatives as new antibiotics and specifically designed molecular sensors

next article

08.08.2008

An increasing problem in modern medicine is the growing resistance of microorganisms against antibiotics and the resulting race for new antibiotic candidates. Inventors from the University of Dortmund have found a way to get to both, new antibiotics and a method to identify them. Common thiopeptides like thiostrepton are potent inhibitors of the bacterial protein-biosynthesis. Most prokaryotic ribosomes are known to be thiopeptide sensitive. Mitochondrial ribosomes from protozoa (e.g. Plasmodium, Toxoplasma) and from multicellular organisms (cancer cell lines) are also affected, but not the cytoplasmic ribosomes in eukaryotes. No thiopeptide antibiotic is in human pharmaceutical application so far. The inventions provide novel compounds binding not only to prokaryotic but also to mitochondrial ribosomes. The disclosed compounds are thiostrepton derivatives and inhibit protein biosynthesis. They are stable and show both high affinity and selectivity.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Contact
Dipl.-Ing. Alfred Schillert

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

info@technologieallianz.de | Source: TechnologieAllianz e.V.
Further information: www.technologieallianz.de/angebote.php?sort=sag&id=1351&lang=en
www.technologieallianz.de

next article